SCHEMBL3053597

SCHEMBL3053597

CCCCc1ccc(S)c(S)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.50
HPGD P15428 2/20 0.45
NPC1 O15118 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CA2 P00918 2/20 0.44
CA1 P00915 1/20 0.44
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 3/20 0.41
ESR1 P03372 2/20 0.41
ADRA2A P08913 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
TACR2 P21452 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30883022 1.00 SKP2 (0.50) SKP2HPGDNPC1MAPK1HTT
SCHEMBL10349019 0.92 PTGS2 (0.52) ALDH1A1HSD17B10CYP3A4ESR1ADRA2A
SCHEMBL6661848 0.83 SKP2 (0.56) SKP2HPGDNPC1MAPK1HTT
SCHEMBL333653 0.83 SKP2 (0.61) SKP2HPGDNPC1MAPK1HTT
SCHEMBL11124259 0.82 SKP2 (0.59) SKP2HPGDNPC1MAPK1HTT
SCHEMBL10411345 0.82 NPC1 (0.55) SKP2HPGDNPC1MAPK1HTT
SCHEMBL11467020 0.82 SKP2 (0.65) SKP2HPGDNPC1MAPK1HTT
SCHEMBL8553254 0.80 SKP2 (0.62) SKP2HPGDNPC1MAPK1HTT
SCHEMBL9338279 0.79 PPARG (0.48) SKP2CYP3A4KDM4ECYP2D6CYP2C9
SCHEMBL9334739 0.77 SMN1; SMN2 (0.51) SKP2NPC1MAPK1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113838990-B Quantum dot light emitting device, manufacturing method thereof and display device 北京京东方技术开发有限公司 2024-04-09 CN disclosed
CN-113838990-A Quantum dot light-emitting device, manufacturing method thereof and display device 北京京东方技术开发有限公司 2021-12-24 CN disclosed
US-20100222477-A1 FILLER FOR SUBSTRATE AND COMPOSITION FOR USE AS MATERIAL FOR INORGANIC/ORGANIC COMPOSITE SUBSTRATE FORMATION NISSHINBO INDUSTRIES, INC. (JP) 2010-09-02 US disclosed
US-20100160512-A1 FLAME RETARDANT AND INORGANIC/ORGANIC COMPOSITE FLAME-RETARDANT COMPOSITION NISSHINBO INDUSTRIES, INC. (JP) 2010-06-24 US disclosed
US-7387832-B2 Flat particles and process for production thereof NISSHINBO INDUSTRIES, INC. (JP) 2008-06-17 US disclosed
US-20080124552-A1 Particle With Rough Surface For Plating Or Vapor Deposition NISSHINBO INDUSTRIES, INC. (JP) 2008-05-29 US disclosed
EP-1900769-A1 FLAME RETARDANT AND INORGANIC/ORGANIC COMPOSITE FLAME-RETARDANT COMPOSITION Nisshinbo Industries, Inc. (JP) 2008-03-19 EP disclosed
EP-1894967-A1 FILLER FOR SUBSTRATE AND COMPOSITION FOR USE AS MATERIAL FOR INORGANIC/ORGANIC COMPOSITE SUBSTRATE FORMATION Nisshinbo Industries, Inc. (JP) 2008-03-05 EP disclosed
US-7258921-B2 Composite particle with a carbodiimide resin layer and a process for producing the same NISSHINBO INDUSTRIES, INC. (JP) 2007-08-21 US disclosed
US-20060052549-A1 Flat particles and process for production thereof NISSHINBO INDUSTRIES, INC. (JP) 2006-03-09 US disclosed
US-20050271875-A1 Composite particle with a carbodimide resin layer and process for producing the same NISSHINBO INDUSTRIES, INC. (JP) 2005-12-08 US disclosed
EP-1553124-A1 FLAKY PARTICLES AND PROCESS FOR PRODUCTION THEREOF Nisshinbo Industries, Inc. (JP) 2005-07-13 EP disclosed
US-20050118424-A1 particles comprising thermoplastic resins impregnated with carbodiimide compounds, having heat and solvent resistance, used as curing agents, stabilizers, hardeners, adhesives, coatings, paints, reinforcements and in automobiles, electronics, furniture, construction materials and as spacers TAKAHASHI IKUO (JP) 2005-06-02 US disclosed
EP-1528077-A1 COMPOSITE PARTICLE HAVING CARBODIIMIDE RESIN LAYER AND PROCESS FOR PRODUCING THE SAME Nisshinbo Industries, Inc. (JP) 2005-05-04 EP disclosed
US-6866934-B2 A thermoplastic resin having a functional group and carbodiimide compound impregnated only in the surface layer section or both surface layer section and inside the base particle and both are strongly bonded by crosslinking reaction NISSHINBO INDUSTRIES, INC. (JP) 2005-03-15 US disclosed
US-20030215636-A1 A thermoplastic resin having a functional group and carbodiimide compound impregnated only in the surface layer section or both surface layer section and inside the base particle and both are strongly bonded by crosslinking reaction NISSHINBO INDUSTRIES, INC. (JP) 2003-11-20 US disclosed
EP-0742201-B1 PROCESS FOR PRODUCING AROMATIC OR HETEROAROMATIC SULFUR COMPOUNDS SUMITOMO SEIKA CHEMICALS (JP) 2003-02-05 EP disclosed
US-5932731-A HYDROLYZING A HETEROAROMATIC HALOGENATED METHYL SULFIDE IN PRESENCE OF AN ACID SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1999-08-03 US disclosed
US-5741933-A HYDROLYSIS; OXIDATION SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1998-04-21 US disclosed
EP-0742201-A1 PROCESS FOR PRODUCING AROMATIC OR HETEROAROMATIC SULFUR COMPOUNDS SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1996-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160512-A1 FLAME RETARDANT AND INORGANIC/ORGANIC COMPOSITE FLAME-RETARDANT COMPOSITION AFF1, H1-0, H1-4 SKP2 2999/4885HPGD 3965/4885NPC1 3910/4885
US-20100222477-A1 FILLER FOR SUBSTRATE AND COMPOSITION FOR USE AS MATERIAL FOR INORGANIC/ORGANIC COMPOSITE SUBSTRATE FORMATION H1-0, CHRM1, H1-3 SKP2 3573/4885HPGD 1377/4885NPC1 3629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.